The University of Western Ontario

Barnett, H.J.M., M. Eliasziw, and H.E. Meldrum. Aug. 1995. The Identification by Imaging Methods of Patients Who Might Benefit from Carotid Endarterectomy. Archives of Neurology 52: 827-831.

Barnett, H.J.M., M. Eliasziw, H.E. Meldrum, and D.W. Taylor. March 1996. Do the Facts and Figures Warrant a 10-fold Increase in the Performance of Carotid Endarterectomy on Asymptomatic Patients? Neurology 46: 603-608.

Barnett, H.J.M., M. Kaste, H.E. Meldrum, and M. Eliasziw. 1996. Aspirin Dose in Stroke Prevention: Beautiful Hypotheses Slain by Ugly Facts. Stroke 27: 588-592.

Barnett, H.J.M., H.E. Meldrum, and M. Eliasziw. 1995. The Dilemma of Surgical Treatment for Patients with Asymptomatic Carotid Disease. Annals of Internal Medicine 123 (9): 723-725.

Barnett, H.J.M., H.E. Meldrum, and M. Eliasziw. 1996. Lessons from the Symptomatic Trials for the Management of Asymptomatic Disease. (Chapter 33). Cerebrovascular Ischaemia Investigation and Management. L.R. Caplan, E.G. Shifrin, A.N. Nicolaides, and W.S. Moore. London: Med-Orion Publishing Company. 383-392.

Eliasziw, M., L.M. Paddock-Eliasziw, and H.J.M. Barnett. 1996. Application of the CHAT Classification to Patients in the NASCET (Chapter 55). Cerebrovascular Ischaemia Investigation and Management. L.R. Caplan, E.G. Shifrin, A.N. Nicolaides, and W.S. Moore. London: Med-Orion Publishing Company. 697-702.

Eliasziw, M., R.N. Rankin, A.J. Fox, R.B. Haynes, H.J.M. Barnett, and North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. 1995. Accuracy and Prognostic Consequences of Ultrasonography in Identifying Severe Carotid Artery Stenosis. Stroke 26 (10): 1747-1752.

Gasecki, A.P., M. Eliasziw, G.G. Ferguson, V. Hachinski, H.J.M. Barnett, and NASCET Group. 1995. Long-term prognosis and effect of carotid endarterectomy in patients with symptomatic severe carotid stenosis and contraleral stenosis or occlusion: results from NASCET. Journal of Neurosurgery 83 (Nov.): 778-782.

Meldrum, H.E., H.J.M. Barnett, and M. Eliasziw. 1995. Carotid Endarterectomy: Emerging Indications (Chapter 8). Bailliere's Clinical Neurology: International Practice and Research. V. Hachinski. London: Bailliere Tindall. 339-355. Cerebrovascular Disease, Volume 4(2).

Blume, W.T. 1995. Physiology of Atonic Seizures (Chapter 13). Negative Motor Phenomena, Advances in Neurology, Volume 67. H.O. Luders, and C.D. Marsden. Philadelphia, PA: Lippincott-Raven Press. 173-179.

Blume, W.T., and L.M. Oliver. 1996. Noninvasive Electorencephalography in Supplementary Sensorimotor Area Epilepsy (Chapter 28). Advances in Neurology, Volume 70: Supplementary Sensorimotor Area. H.O. Luders. Philadelphia, PA: Lippincott-Raven Publishers. 309-317.

Kanazawa, O., W.T. Blume, and J.P. Girvin. 1996. Significance of Spikes During Temporal Lobe Electrocorticography. Epilepsia 37 (1): 50-55.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Bolton, C.F. 1995. Critical Illness Polyneuropathy. Peripheral Nerve Disorders. P.K. Thomas, and A. Asbury. Butterworth-Heinemann. 262-280.

Bolton, C.F. 1995. Diabetic Polyneuropathy in controlled clinical trials: Consensus report of the peripheral nerve society. Annals of Neurology 38 (3): 478-482.

Bolton, C.F. 1995. Guillian-Barre Syndrome (Editorial). New England Journal of Medicine 333 (21): 1415-1417.

Bolton, C.F. 1996. Neuromuscular conditions in the intensive care unit (Editorial). Intensive Care Medicine 22: 841-843.

Bolton, C.F. 1996. Sepsis and the systemic inflammatory response syndrome (SIRS): neuromuscular manifestations. Critical Care Medicine 24 (8): 1408-1416.

Bolton, C.F., M. Harper, and H.R. Jones. 1996. Paediatric Electromyography. Philadelphia, PA: Lippincott-Raven.

Bolton, C.F., and G.B. Young. 1996. Neurologic Manifestations of Renal Failure and Dialysis (Chapter 185, Section 3). Office Practice of Neurology. New York, NY: Churchill Livingstone. 999-1005.

Chen, R.E., F. Grand'Maison, M.J. Strong, D.A. Ramsay, and C.F. Bolton. 1996. Motor Neuron Disease Presenting as Acute Respiratory Failure: A Clinical and pathological study. Journal of Neurology, Neurosurgery and Psychiatry 60: 455-458.

Chen, R., C.F. Bolton, and G.B. Young. 1996. Prediction of Outcome in Patients with Anoxic Coma: A clinical and electrophysiologic study. Critical Care Medicine 24 (4): 672-678.

Chen, R., S.J. Collins, H. Remtulla, A. Parkes, and C.F. Bolton. 1996. Needle EMG of the human diaphram: Power spectral analysis in normal suabjects. Muscle and Nerve 19: 324-330.

Maher, J., F.S. Rutledge, H. Remtulla, A. Parkes, L. Bernardi, and C.F. Bolton. 1995. Neuromuscualr disorders associated with failure to wean from the ventilator. Intensive Care Medicine 21: 737-743.

Sheth, R.D., and C.F. Bolton. 1995. Neuromuscular complications of sepsis in children. Journal of Child Neurology 10: 346-352.

Zifko, U.A., R. Chen, H. Remtulla, A.F.G. Hahn, W. Koopman, and C.F. Bolton. 1996. Respiratory electrophysiologic studies in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery and Psychiatry 60: 191-194.

Zifko, U.A., H. Remtulla, K. Power, L.A. Harker, and C.F. Bolton. 1996. Transcortical and cervical magnetic stimulation with recording of the diaphragm. Muscle & Nerve 19: 614-620.

Zifko, U.A., P.J. Slomka, R.H. Reid, G.B. Young, H. Remtulla, and C.F. Bolton. 1996. The cortical representation of somatosensory evoked potentials of the phrenic nerve. Journal of the Neurological Sciences 139: 197-202.

Zifko, U.A., P.J. Slomka, G.B. Young, R.H. Reid, and C.F. Bolton. 1996. Brain Mapping of Median Nerve Somatosensory Evoked Potentials with Combined ^99mTc-ECD single-photon emission tomography and magnetic resonance imaging. European Journal of Nuclear Medicine 23 (5): 579-582.

Zifko, U.A., G.B. Young, H. Remtulla, and C.F. Bolton. 1995. Somatosensory Evoked Potentials of the Phrenic Nerve. Muscle and Nerve 18 (Dec.): 1487-1489.

Dowdy, P.A., B.V. Watson, A. Amendola, and J.D. Brown. 1996. Non-invasive Ankle Distraction: Relationship Between Force, Magnitude of Distraction, and Nerve Conduction Abnormalities. Arthroscopy: The Journal of Arthroscopic and Related Surgery 12 (1): 64-69.

Wu, M., and S.M. Brudzynski. 1995. Mesolimbic dopamine terminals and locomotor activity induced from the subiculum. NeuroReport 6 (12): 1601-1604.

Sadovnick, A.D., G.C. Ebers, D.A. Dyment, N.J. Risch, Canadian Collaborative Study Group , D.E. Bulman, and G.P.A. Rice. 1996. Evidence for genetic basis of multiple sclerosis. Lancet 347 (June): 1728-1730.

Bacchus, J.N., and J.G. Cairncross. 1995. Conservative treatment of low grade glioma. Controversies in Neurosurgery. New York, NY: Thieme Medical Publishers Inc. 55-63.

Cairncross, J.G. 1995. Low grade glioma - the case for delayed surgery. Clinical Neurosurgery, Volume 42. Baltimore: Williams and Wilkins. 391-398.

Forsyth, P.A.J., and J.G. Cairncross. 1995. Treatment of malignant glioma in adults. Current Opinion in Neurology, Volume 8. London, U.K: Current Science. 414-418.

Halperin, E.C., J. Herndon, S. Schold, M. Brown, N. Vick, J.G. Cairncross, D.R. Macdonald, L.E.W. Gaspar, B.J. Fisher, E. Dropcho, S. Rosenfeld, et al. 1996. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology, Biology, Physics 34 (4): 793-802.

Kirby, S., M. Brothers, W. Irish, R. Florell, D.R. Macdonald, C. Schold, and J.G. Cairncross. 1995. Evaluating glioma therapies. Modeling treatments and predicting outcomes. Journal of the National Cancer Institute 87 (24): 1884-1888.

Kirby, S., D.R. Macdonald, B.J. Fisher, L.E.W. Gaspar, and J.G. Cairncross. 1996. Pre-radiation chemotherapy for malignant glioma in adults. Canadian Journal of Neurological Sciences 23 (2): 123-127.

Macdonald, D.R., J.G. Cairncross, D. Stewart, P. Forsyth, C. Sawka, N. Wainman, E. Eisenhauer, and National Clinical Institute of Canada Clinical Trials Group (NCIC CTG). 1996. Phase II study of topotecan in patients with recurrent malignant glioma. Annals of Oncology 7: 205-207.

Nutt, C.L., A.F. Chambers, and J.G. Cairncross. 1996. Wild-type p53 renders mouse astrocytes resistant to 1,3-Bis(2-chloroethyl)-1-nitrosourea despite the absense of a p-53-dependent cell cycle arrest. Cancer Research Advances in Brief 56: 2748-2751.

Nutt, C.L., J.F. Costello, L.L. Bambrick, D.B. Yarosh, L.E. Swinnen, A.F. Chambers, and J.G. Cairncross. 1995. O6-methylguanine-DNA methyltransferase in tumours and cells of the oligodendrocyte lineage. Canadian Journal of Neurological Sciences 22: 111-115.

Peterson, K., and J.G. Cairncross. 1995. Oligodendroglioma. Neurologic Clinics, Volume 13. Philadelphia, PA: W.B. Saunders. 861-873.

Peterson, K., and J.G. Cairncross. 1996. Oligodendroglioma. Cancer Investigation 14 (3): 243-251.

Scott, J.A., N.B. Rewcastle, P. Brasher, J. MacKinnon, N. Hagen, J.G. Cairncross, and P.A.J. Forsyth. 1996. Which GBM patient will be a long-term survivor? A case-controlled, population-based study in southern Alberta. Neurology 46: 181.

Watling, C.J., D.J. Van Meyel, D.A. Ramsay, D.R. MacDonald, and J.G. Cairncross. 1995. Loss of heterozygosity analysis of chromosomes 9, 10 and 17 in gliomas in families. Canadian Journal of Neurological Sciences 22: 17-21.

Allen, G.V., and D.F. Cechetto. 1995. Neurotensin in the Lateral Hypothalamic Area: Origin and Function. Neuroscience 69 (2): 533-544.

Allen, G.V., R.T.F. Cheung, and D.F. Cechetto. 1995. Neurochemical Changes Following Occlusion of the Middle Cerebral Artery in Rats. Neuroscience 68 (4): 1037-1050.

Butcher, K., and D.F. Cechetto. 1995. Autonomic Responses of the Insular Cortex in Hypertensive and Normotensive Rats. American Journal of Physiology 268: 214-222.

Butcher, K., and D.F. Cechetto. 1995. Insular Lesion Evokes Autonomic Effects of Stroke in Normotensive and Hypertensive Rats. Stroke 26: 459-465.

Cechetto, D.F. 1995. Supraspinal Mechanisms of Visceral Representation (Chapter 11). Visceral Pain. Progress in Pain Research and Management, Vol. 5. G.F. Gebhart. Seattle, WA: IASP Press. 261-290.

Cheung, R.T.F., and D.F. Cechetto. 1995. Neuropeptide Changes Following Excitotoxic Lesion of the Insular Cortex in Rats. Journal of Comparative Neurology 362: 535-550.

Cheung, R.T.F., T. Diab, and D.F. Cechetto. 1995. Time-course of Neuropeptide Changes in the Peri-Ischemic Zone and Amygdale Following Focal Ischemia in Rats. Journal of Comparative Neurology 360: 101-120.

Saleh, A., and D.F. Cechetto. 1995. Neurochemical Interactions in the Parabrachial Nucleus Mediating Visceral Inputs to Visceral Thalamic Neurons. American Journal of Physiology 268: R786-R795.

Saleh, T.M., and D.F. Cechetto. 1996. Peptide Changes in the Parabrachial Nucleus Following Cervical Vagal Stimulation. Journal of Comparative Neurology 366: 390-405.

Cooper, P.E. 1996. Neuroendocrinology in Neurology. Clinical Practice. 2nd ed. Boston, MA: Butterworth-Heineman. 743-761.

Brodland, G.W., M.J. Scott, A.F. MacLean, M. Globus, S. Vethamany-Globus, R. Gordon, J.H. Veldhuis, and R.F. Del Maestro. 1996. Morphogenetic movements during axolotl neural tube formation tracked by ditital imaging. Roux's Archives of Developmental Biology 205: 311-318.

Del Maestro, R.F. 1996. Leonardo da Vinci, The Search for the Soul Exhibition. London, Ontario: 48 pp. Exhibition Catalogue.

Li, Y.S., D.A. Ramsay, Y.S. Fan, R.F. Armstrong, and R.F. Del Maestro. 1995. Cytogenetic Evidence that a Tumor Suppressor Gene in the Long Arm of Chromosome 1 Contributes to Glioma Growth. Cancer Genetics and Cytogenetics 84: 46-50.

Pahapill, P.A., D.A. Ramsay, and R.F. Del Maestro. 1996. Pleomorphic xanthoastrocytoma: A case report, review of the literature and proposal for two clinicolpathological subtypes. Journal of Neurosurgery 38 (4): 822-829.

Ramsay, D.A., Y.S. Fan, R.F. Armstrong, R.F. Del Maestro, and Y.S. Li. 1995. Chromosome abnormalities in glioma with particular reference to extra dark bands on the tip of the short arm of chromsome I. Cancer Genetics and Cytogenetics 84: 46-50.

Tamaki, M., W. McDonald, and R.F. Del Maestro. 1996. Release of collagen type IV degrading activity from C6 astrocytoma cells is dependent of cell density. Journal of Neurosurgery 84: 1013-1019.

Ebers, G.C. 1996. Genetic epidemiology of multiple sclerosis. Current Opinion in Neurology & Neurosurgery 9 (3): 155-159.

Ebers, G.C., A.D. Sadovnick, N.J. Risch, and Canadian Collaborative Study Group. 1995. A genetic basis for familial aggregation in multiple sclerosis. Nature 377: 150-151.

The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group, W.A. Sibley, G.C. Ebers, F.D. Lublin, and D.W. Paty. 1995. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45 (July): 1277-1285.

Rice, G.P.A., and G.C. Ebers. 1995. Management of Multiple Sclerosis in Women. The Female Patient 20 (Sept.): 19-33.

Sadovnick, A.D., G.C. Ebers, D.A. Dyment, N.J. Risch, Canadian Collaborative Study Group , D.E. Bulman, and G.P.A. Rice. 1996. Evidence for genetic basis of multiple sclerosis. Lancet 347 (June): 1728-1730.

Barnett, H.J.M., M. Eliasziw, and H.E. Meldrum. Aug. 1995. The Identification by Imaging Methods of Patients Who Might Benefit from Carotid Endarterectomy. Archives of Neurology 52: 827-831.

Barnett, H.J.M., M. Eliasziw, H.E. Meldrum, and D.W. Taylor. March 1996. Do the Facts and Figures Warrant a 10-fold Increase in the Performance of Carotid Endarterectomy on Asymptomatic Patients? Neurology 46: 603-608.

Barnett, H.J.M., M. Kaste, H.E. Meldrum, and M. Eliasziw. 1996. Aspirin Dose in Stroke Prevention: Beautiful Hypotheses Slain by Ugly Facts. Stroke 27: 588-592.

Barnett, H.J.M., H.E. Meldrum, and M. Eliasziw. 1995. The Dilemma of Surgical Treatment for Patients with Asymptomatic Carotid Disease. Annals of Internal Medicine 123 (9): 723-725.

Barnett, H.J.M., H.E. Meldrum, and M. Eliasziw. 1996. Lessons from the Symptomatic Trials for the Management of Asymptomatic Disease. (Chapter 33). Cerebrovascular Ischaemia Investigation and Management. L.R. Caplan, E.G. Shifrin, A.N. Nicolaides, and W.S. Moore. London: Med-Orion Publishing Company. 383-392.

Donner, A.P., M. Eliasziw, and N. Klar. March 1996. Testing the Homogeneity of Kappa Statistics. Biometrics 52: 176-183.

Eliasziw, M., and A.P. Donner. 1995. Evaluation of a Proposed Modification to the Pairwise Estimator of a Parent-Offspring Correlation. Sankhya: The Indian Journal of Statistics 57 (B, Pt.1): 151-157.

Eliasziw, M., L.M. Paddock-Eliasziw, and H.J.M. Barnett. 1996. Application of the CHAT Classification to Patients in the NASCET (Chapter 55). Cerebrovascular Ischaemia Investigation and Management. L.R. Caplan, E.G. Shifrin, A.N. Nicolaides, and W.S. Moore. London: Med-Orion Publishing Company. 697-702.

Eliasziw, M., R.N. Rankin, A.J. Fox, R.B. Haynes, H.J.M. Barnett, and North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. 1995. Accuracy and Prognostic Consequences of Ultrasonography in Identifying Severe Carotid Artery Stenosis. Stroke 26 (10): 1747-1752.

Erkinjuntti, T., O. Benavente, M. Eliasziw, D.G. Munoz, R. Sulkava, M. Haltia, and V. Hachinski. 1996. Diffuse Vacuolization (Spongiosis) and Arteriolosclerosis in the Frontal White Matter Occurs in Vascular Dementia. Archives of Neurology 53 (April): 325-332.

Fung, J.J., M. Eliasziw, S. Todo, A. Jain, A.J. Demetris, J.P. McMichael, T.E. Starzl, P. Meier, and A.P. Donner. 1996. The Pittsburgh Randomized Trial of Tacrolimus Compared to Cyclosporine for Hepatic Transplantation. Journal of the American College of Surgeons 183: 117-125.

Gasecki, A.P., M. Eliasziw, G.G. Ferguson, V. Hachinski, H.J.M. Barnett, and NASCET Group. 1995. Long-term prognosis and effect of carotid endarterectomy in patients with symptomatic severe carotid stenosis and contraleral stenosis or occlusion: results from NASCET. Journal of Neurosurgery 83 (Nov.): 778-782.

Herrick, I.A., S. Ganapathy, W. Komar, W.K.J. Kirkby, C.A. Moote, W.B. Dobkowski, and M. Eliasziw. April 1996. Postoperative Cognitive Impairment in the Elderly: Choice of Patient-Controlled Analgesia Opioid. Anaesthesia 51: 356-360.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Meldrum, H.E., H.J.M. Barnett, and M. Eliasziw. 1995. Carotid Endarterectomy: Emerging Indications (Chapter 8). Bailliere's Clinical Neurology: International Practice and Research. V. Hachinski. London: Bailliere Tindall. 339-355. Cerebrovascular Disease, Volume 4(2).

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Evaluating the Impact on Operator Performance of Quantification Algorithms. Medical Imaging 1996 - Image Processing. Newport Beach, CA: 12 February 1996-15 February 1996. SPIE Proceedings, Volume 2710. Bellingham, Washington: Society of Photo-Optical Instrumentation Engineers (SPIE). 524-533.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5T anisotropically filtered and unfiltered MR exams. Medical Physics 23 (1): 115-126.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Medical Physics 23 (1): 85-97.

Starzl, T.E., A.P. Donner, M. Eliasziw, L.W. Stitt, P. Meier, J.J. Fung, J.P. McMichael, and S. Todo. Nov. 1995. Randomised Trialomania? The Multicentre Liver Transplant Trials of Tacrolimus. Lancet 346: 1346-1350.

Vellet, A.D., D.H. Lee, P.L. Munk, L. Hewett, M. Eliasziw, S. Dunlavy, L.J. Vidito, P.J. Fowler, A. Miniaci, and A. Amendola. 1995. Anterior Cruciate Ligament Tear: Prospective Evaluation of Diagnostic Accuracy of Middle- and High-Field Strength MR Imaging at 1.5 and 0.5 T. Radiology 197 (3): 826-830.

Ferguson, G.G., and Executive Committee ACAS. 1995. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 273: 1421-1428.

Findlay, J.M., N.F. Kassell, B.K.A. Weir, E.C. Haley, G. Kongable, T. Germanson, L. Truskowski, W.M. Alves, R.O. Holness, N.W. Knuckey, H. Yonas, G.K. Steinberg, M. West, H.R. Winn, and G.G. Ferguson. 1995. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm. Neurosurgery 37 (1): 168-178.

Gasecki, A.P., M. Eliasziw, G.G. Ferguson, V. Hachinski, H.J.M. Barnett, and NASCET Group. 1995. Long-term prognosis and effect of carotid endarterectomy in patients with symptomatic severe carotid stenosis and contraleral stenosis or occlusion: results from NASCET. Journal of Neurosurgery 83 (Nov.): 778-782.

Dywan, C.A., J.M. McGlone, and A.J. Fox. 1995. Do Intracarotid Barbiturate Injections Offer a Way to Investigate Hemispheric Models of Anosognosia? Journal of Clinical and Experimental Neuropsychology 17 (3): 431-438.

Eliasziw, M., R.N. Rankin, A.J. Fox, R.B. Haynes, H.J.M. Barnett, and North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. 1995. Accuracy and Prognostic Consequences of Ultrasonography in Identifying Severe Carotid Artery Stenosis. Stroke 26 (10): 1747-1752.

Fox, A.J. 1996. Neuroradiology Subspecialty Recognition. The Canadian Model: Accreditation Without Certification. International Journal of Neuroradiology 2 (1): 100-101.

Craen, R.A., J.E. Blaszkow, W. Komar, A.W. Gelb, and I.A. Herrick. 1996. Awake Craniotomy. London, Ontario: London Health Sciences Centre. Patient Teaching Video for Epilepsy Service.

Gelb, A.W. 1996. The Nervous System at Risk - An Overview . ACTA Anaesthesiologica Scandinavia 40 (Supplement 109): 48-50.

Gelb, A.W., and A.D.J. Watts. 1996. Anesthesia for Neurovascular Surgery. Anesthesia and Analgesia 83 (Supplement): 46-51.

Gelb, A.W., C. Zhang, and J.T. Hamilton. 1996. Propofol Induces Dilation and Inhibits Constriction in Guinea Pig Basilar Arteries. Anesthesia and Analgesia 83: 472-476.

Herrick, I.A., A.W. Gelb, B.D. Nichols, and J. Kirby. 1996. Patient-Controlled Propofol Sedation for Elderly Patients: Safety and Patient Attitude Toward Control. Canadian Journal of Anaesthesia 43 (10): 1014-1018.

Manninen, P.H., B. Ayra, A.W. Gelb, and D.M. Pelz. 1996. Association Between Electrocardiographic Abnormalities and Intracranial Blood in Patients Following Acute Subarachnoid Hemorrhage. Journal of Neurosurgical Anesthesiology 7 (1): 12-16.

Kanazawa, O., W.T. Blume, and J.P. Girvin. 1996. Significance of Spikes During Temporal Lobe Electrocorticography. Epilepsia 37 (1): 50-55.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Bowler, J.V., and V. Hachinski. 1996. Epidemiology of Cerebral Infarction (Chapter 1). Atlas of Cerebrovascular Disease. P.B. Gorelick. Philadelphia, PA: Current Medicine. 13-117.

Bowler, J.V., and V. Hachinski. 1996. History of the Concept of Vascular Dementia: Two Opposing Views on Current Definitions and Criteria for Vascular Dementia (Chapter 1). Vascular Dementia: Current Concepts. I. Prohovnik, J. Wade, Knezevic, T. Tatemichi, and T. Erkinjuntti. Toronto, Ontario: John Wiley & Sons Ltd. 1-28.

Bowler, J.V., and V. Hachinski. 1995. Vascular cognitive impairment: a new approach to vascular dementia (Chapter 9). Baillière's Clinical Neurology: International Practice and Research: Cerebrovascular Disease 4 (2): 357-376.

Del-Ser, T., D.G. Munoz, and V. Hachinski. 1996. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 46 (March): 682-686.

Díez-Tejedor, E., A. de Leciñana, and V. Hachinski. 1996. Manejo del paciente con infarto cerebral en fase aguda//Management of the patient with stroke in the acute phase. Revista De Neurologia 24 (125): 40-54. Spanish text.

Egido, J.A., and V. Hachinski. 1995. Manejo del ictua: entre lo deseable y lo imprescindible. Anales de Medicina Interna 12 (8): 365-368.

Erkinjuntti, T., O. Benavente, M. Eliasziw, D.G. Munoz, R. Sulkava, M. Haltia, and V. Hachinski. 1996. Diffuse Vacuolization (Spongiosis) and Arteriolosclerosis in the Frontal White Matter Occurs in Vascular Dementia. Archives of Neurology 53 (April): 325-332.

Gasecki, A.P., M. Eliasziw, G.G. Ferguson, V. Hachinski, H.J.M. Barnett, and NASCET Group. 1995. Long-term prognosis and effect of carotid endarterectomy in patients with symptomatic severe carotid stenosis and contraleral stenosis or occlusion: results from NASCET. Journal of Neurosurgery 83 (Nov.): 778-782.

Hachinski, V. (Editor). 1995. Bailliere's Clinical Neurology: Cerebrovascular Disease. 4 (2). V. Hachinski (Guest Editor).

Hachinski, V. 1996. Stroke Prevention. Proceedings of the 23rd Congress of the International Society of Internal Medicine. Bologna, Italy: International Proceedings Division. 257-261.

Hachinski, V., C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A.P. Donner, J.D. Spence, G.S. Doig, and B.M. Wolfe. 1996. Lipids and Stroke: A paradox resolved. Archives of Neurology 53 (April): 303-308.

Hachinski, V., and Writing Committee for Lancet Conference . 1996. The challenge of the dementia's. Lancet 347: 1303-1307.

Hahn, A.F.G. 1996. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies. Reveue Neuroligique 152 (5): 328-332.

Tan, C.C., P.J. Ainsworth, A.F.G. Hahn, and P.M. MacLeod. 1996. Novel mutations in the connexin 32 gene associated with x-linked Charcot-Marie-Tooth disease. Human Mutation 7: 167-171.

Zifko, U.A., R. Chen, H. Remtulla, A.F.G. Hahn, W. Koopman, and C.F. Bolton. 1996. Respiratory electrophysiologic studies in Guillain-Barré syndrome. Journal of Neurology, Neurosurgery and Psychiatry 60: 191-194.

Karlik, S.J. 1995. Use of NMR Spectroscopy to Measure Intracellular Ion Concentrations. Methods in Neurosciences 27: 39-51.

Karlik, S.J., R.T. Stavraky, and E.D. Hall. 1996. Comparison of tirilazad mesylate (U-74006F) and methyl prednisolone sodium succinate treatments in experimental allergic encephalomyelitis in the guinea pig. Multiple Sclerosis 1: 228-235.

Kent, S.J., S.J. Karlik, G.P.A. Rice, and H.C. Horner. 1995. A Monoclonal Antibody to a 4-Integrin Reverses the MR-Detectable Signs of Experimental Allergic Encephalomyelitis in the Guinea Pig. Journal of Magnetic Resonance Imaging 5 (5): 535-540.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Evaluating the Impact on Operator Performance of Quantification Algorithms. Medical Imaging 1996 - Image Processing. Newport Beach, CA: 12 February 1996-15 February 1996. SPIE Proceedings, Volume 2710. Bellingham, Washington: Society of Photo-Optical Instrumentation Engineers (SPIE). 524-533.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5T anisotropically filtered and unfiltered MR exams. Medical Physics 23 (1): 115-126.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Medical Physics 23 (1): 85-97.

Kertesz, A. 1996. Les agnosies (Chapitre XXV). Neuropsychologie clinique et neurologie du comportement. 2nd ed. M.I. Botez, and M.L. Albert. Montreal, PQ: University of Montreal Press. 435-454. French text.

Kertesz, A. 1996. Les apraxies (Chapitre XXIV). Neuropsychologie clinique et neurologie du comportement. 2nd ed. M.I. Botez, and M.L. Albert. Montreal, PQ: University of Montreal Press. 417-433. French text.

Kertesz, A. 1995. Die Restitution der Aphasie nach Schlaganfall. Neurologie Und Rehabilitation 2: 75-80.

Kertesz, A. 1996. Pick Complex and Pick's Disease: the nosology of frontal lobe dementia, primary progressive aphasia, and corticobasal ganglionic degeneration. European Journal of Neurology 3: 280-282.

Kertesz, A., and R. Mohs. 1996. Cognition (Chapter 10). The Clinical Diagnosis and Management of Alzheimer's Disease. S. Gauthier. London: Martin Dunitz Ltd. 155-174.

Kertesz, A., and D.G. Munoz. 1996. Clinical and pathological characteristics of primary progrssive aphasia and frontal dementia. Journal of Neural Transmission 47 (Supplement): 133-141.

Squire, I.B., K.R. Lees, W. Pryse-Phillips, A. Kertesz, J. Bamford, and Lifarizine Study Group. 1996. The effects of Lifarizine in acute cerebral infarction: A pilot safety study. Cerebrovascular Diseases 6: 156-160.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Evaluating the Impact on Operator Performance of Quantification Algorithms. Medical Imaging 1996 - Image Processing. Newport Beach, CA: 12 February 1996-15 February 1996. SPIE Proceedings, Volume 2710. Bellingham, Washington: Society of Photo-Optical Instrumentation Engineers (SPIE). 524-533.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5T anisotropically filtered and unfiltered MR exams. Medical Physics 23 (1): 115-126.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Medical Physics 23 (1): 85-97.

Rutt, B.K., and D.H. Lee. 1996. The Impact of Field Strength on Image Quality in MRI. Journal of Magnetic Resonance Imaging 6 (1): 57-62.

Vellet, A.D., D.H. Lee, P.L. Munk, L. Hewett, M. Eliasziw, S. Dunlavy, L.J. Vidito, P.J. Fowler, A. Miniaci, and A. Amendola. 1995. Anterior Cruciate Ligament Tear: Prospective Evaluation of Diagnostic Accuracy of Middle- and High-Field Strength MR Imaging at 1.5 and 0.5 T. Radiology 197 (3): 826-830.

Leung, L.W.S., and D. Zhao. 1995. Glial potentials evoked by single afferent pulses in hippocampal CA1 area in vitro. Brain Research 697: 262-265.

Roth, L.R., and L.W.S. Leung. 1995. Difference in LTP at basal and apical dendrites of CA1 pyramidal neurons in urethane-anesthetized rats. Brain Research 694: 40-48.

Lownie, S.P. 1996. Cerebral Angiography. Neurological Surgery. 4th ed. J.R. Youmans. Philadelphia, PA: Saunders. 247-309.

Lownie, S.P. 1996. Endovascular Saccular Treatment of Posterior Circulation Aneurysms (Chapter 24). Surgery of Vertebrobasilar Aneurysms: London, Ontario, Experience on 1,767 Patients. C.T.G. Drake, S.J. Peerless, and J.A. Hernesiemi. New York, NY: Springer. 285-299.

Chen, R., D.R. Macdonald, and D.A. Ramsay. 1995. Primary diffuse leptomeningeal oligodendroglioma. Journal of Neurosurgery 83 (Oct.): 724-728.

Halperin, E.C., J. Herndon, S. Schold, M. Brown, N. Vick, J.G. Cairncross, D.R. Macdonald, L.E.W. Gaspar, B.J. Fisher, E. Dropcho, S. Rosenfeld, et al. 1996. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. International Journal of Radiation Oncology, Biology, Physics 34 (4): 793-802.

Kirby, S., M. Brothers, W. Irish, R. Florell, D.R. Macdonald, C. Schold, and J.G. Cairncross. 1995. Evaluating glioma therapies. Modeling treatments and predicting outcomes. Journal of the National Cancer Institute 87 (24): 1884-1888.

Kirby, S., D.R. Macdonald, B.J. Fisher, L.E.W. Gaspar, and J.G. Cairncross. 1996. Pre-radiation chemotherapy for malignant glioma in adults. Canadian Journal of Neurological Sciences 23 (2): 123-127.

Macdonald, D.R., J.G. Cairncross, D. Stewart, P. Forsyth, C. Sawka, N. Wainman, E. Eisenhauer, and National Clinical Institute of Canada Clinical Trials Group (NCIC CTG). 1996. Phase II study of topotecan in patients with recurrent malignant glioma. Annals of Oncology 7: 205-207.

Ramsay, D.A., J. Bonnin, D.R. Macdonald, and L.J. Assis. 1995. Medulloblastomas in late middle age and the elderly: report of 2 cases. Clinical Neuropathology 14 (6): 337-342.

Watling, C.J., D.J. Van Meyel, D.A. Ramsay, D.R. MacDonald, and J.G. Cairncross. 1995. Loss of heterozygosity analysis of chromosomes 9, 10 and 17 in gliomas in families. Canadian Journal of Neurological Sciences 22: 17-21.

Hammond, R.R., and I.R.A. MacKenzie. 1995. Xanthoma Disseminatum with Massive Intracranial Involvement. Clnical Neuropathology 14 (314): 314-321.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

MacKenzie, I.R.A., C. Hao, and D.G. Munoz. 1995. Role of Microglia in Senile Plaque Formation. Neurobiology of Aging 16 (5): 797-804.

MacKenzie, I.R.A., R.S. McLachlan, C.S. Kubu, and L.A. Miller. 1996. Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46: 425-429.

Bayliff, C.D., J. Bruni, S. Cowan, K. Farrell, M. Sadler, R.S. McLachlan, and G.B. Young. 1996. Antiepileptic Drug Therapy. Compendium of Pharmaceuticals and Specialties (CPS). 1996 ed. Ottawa, Ontario: Canadian Pharmaceutical Association. L44-L46.

Derry, P., and R.S. McLachlan. 1996. The MMPI-2 as an adjunct to the diagnosis of pseudoseizures. Seizure 5: 35-40.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

MacKenzie, I.R.A., R.S. McLachlan, C.S. Kubu, and L.A. Miller. 1996. Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46: 425-429.

Maher, J., and R.S. McLachlan. 1995. Febrile Convulsions: Is Seizure duration the most important predictor of temporal lobe epilepsy? Brain 118: 1521-1528.

McLachlan, R.S. 1995. Physician Reporting of Medical Conditions in Canada. Clinics and Cases 4 (3): 7-8.

McLachlan, R.S. 1996. A Young Man with Continuous Abnormal Movements. Challenges in Epilepsy 1 (1)

Rose, K.J., P.A. Derry, and R.S. McLachlan. 1996. Neuroticism in temporal lobe epilepsy: assessment and implications for pre- and postoperative psychosocial adjustment and health-related quality of life. Epilepsia 37 (5): 484-491.

Rose, K.J., P.A. Derry, S. Wiebe-Velazquez, and R.S. McLachlan. 1996. Determinants of HealthRelated Quality of Life after Temporal Lobe Epilepsy Surgery. Quality of Life Research 5: 395-402.

Moulin, D.E. 1996. Medical Management of Chronic Nonmalignant Pain. 1996 ed. Seattle, Washington: IASP Press. 485-492.

Moulin, D.E. 1996. Opioid analgesics for chronic nonmalignant pain. Canadian Journal of Continuing Medical Education 8 (Feb.): 137-143.

Moulin, D.E., A. Iezzi, R. Amireh, W.K.J. Sharpe, D.B. Boyd, and H. Merskey. 1996. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 347 (Jan.): 143-147.

Del-Ser, T., D.G. Munoz, and V. Hachinski. 1996. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 46 (March): 682-686.

Erkinjuntti, T., O. Benavente, M. Eliasziw, D.G. Munoz, R. Sulkava, M. Haltia, and V. Hachinski. 1996. Diffuse Vacuolization (Spongiosis) and Arteriolosclerosis in the Frontal White Matter Occurs in Vascular Dementia. Archives of Neurology 53 (April): 325-332.

Kertesz, A., and D.G. Munoz. 1996. Clinical and pathological characteristics of primary progrssive aphasia and frontal dementia. Journal of Neural Transmission 47 (Supplement): 133-141.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

MacKenzie, I.R.A., C. Hao, and D.G. Munoz. 1995. Role of Microglia in Senile Plaque Formation. Neurobiology of Aging 16 (5): 797-804.

Spence, J.D., D.G. Munoz, L. Hendricks, L. Latchinian, and H.E. Khouri. 1995. Pharmacokinetics of the combination of fluvastatin and gemifibrozil. American Journal of Cardiology 76 (July): 80A-83A.

Wang, D., and D.G. Munoz. 1995. Qualitative and Quantitative Differences in Senile Plaque Dystrophic Neurites of Alzheimer's Disease and Normal Aged Brain. Journal of Neuropathology and Experimental Neurology 54 (4): 548-556.

Belliveau, D.J., and C.C.G. Naus. 1995. Cellular Localization of Gap Junction mRNAs in Developing Rat Brain. Developmental Neuroscience 17: 81-96.

Goldberg, G.S., A.P. Moreno, J.F. Bechberger, S.S. Hearn, R.R. Shivers, D.J. MacPhee, Y. Zhang, and C.C.G. Naus. 1996. Evidence that Disruption of Connexon Particle Arrangements in Gap Junction Plaques is Associated With Inhibition of Gap Junction Communication by a Glycyrrhetinic Acid Derivative. Experimental Cell Research 222: 48-53.

Orlando-Mathur, C.E., J.F. Bechberger, G.S. Goldberg, C.C.G. Naus, G.M. Kidder, and T.G. Kennedy. 1996. Rat Endometrial Stromal Cells Express the Gap Junction Genes Connexins 26 and 43 and Form Functional Gap Junctions During In Vitro Decidualization. Biology of Reproduction 54: 905-913.

Rushlow, W., C.C.G. Naus, and B.A. Flumerfelt. 1996. Somatostatin and the Patch/Matrix Compartments of the Rat Caudate-Putamen. Journal of Comparative Neurology 364: 184-190.

Yamasaki, H., and C.C.G. Naus. 1996. Role of Connexin Genes in Growth Control. Carcinogenesis 17 (6): 1199-1213.

Downey, D.B., D.A. Nicolle, and A. Fenster. 1995. Three-dimensional Orbital Ultrasonography. Canadian Journal of Ophthalmology 30 (7): 395-398.

Downey, D.B., D.A. Nicolle, and A. Fenster. 1995. Three-Dimensional Ultrasound of the Eye. Administrative Radiology Journal 14 (10): 46-50.

Downey, D.B., D.A. Nicolle, M.F. Levin, and A. Fenster. 1996. Three-Dimensional Ultrasound Imaging of the Eye. Eye 10: 75-81.

Liszauer, A.D., S. Brownstein, and D.A. Nicolle. 1996. Pilomatrixoma (Calcifying Epithelioma of Malherbe). Ophthalmic Practice 14 (2): 64-68.

Mikhael, S., D.A. Nicolle, and T. Vilis. 1995. Rotation of Listing's Plane by Horizontal, Vertical and Oblique Prism-induced Vergence. Vision Research 35 (23/24): 3243-3254.

Hawke, S., H. Matsuo, M.W. Nicolle, G. Malcherek, A. Melms, and N. Willcox. 1996. Autoimmune T cells: Hetereogeneity and potential for specific immunotargeting. Immunology Today 17: 307-311.

Matsuo, H., A.P. Batocche, S. Hawke, M.W. Nicolle, L. Jacobson, A. Vincent, J. Newsom-Davis, and N. Willcox. 1995. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor. Journal of Immunology 155: 3683-3692.

Nicolle, M.W., S. Hawke, N. Willcox, and A. Vincent. 1995. Differences in processing of an autoantigen by DR4:Dw4.2 and DR4:Dw14.2 antigen-presenting cells. European Journal of Immunology 25: 2119-2122.

Hanson, W., and L.S. Parnes. 1995. Vestibular Nerve Compression in Camurati-Engelmann Disease (Imaging Case Study of the Month). Annals of Otology, Rhinology & Laryngology 104 (10): 823-825.

Parnes, L.S. 1996. Posterior Semicircular Canal Occlusion (Chapter 146). Atlas of Head and Neck Surgery - Otolaryngology. B.J. Bailey, K.H. Calhoun, A.R. Coffey, and J.G. Neely. New York, NY: Lippincott - Raven. 384-385.

Parnes, L.S. 1996. Update on Posterior Canal Occlusion for Benign Paroxysmal Positional Vertigo. Otolaryngologic Clinics of North America 29 (2): 333-342.

Sun, A.H., L.S. Parnes, and D.J. Freeman. 1996. Comparative Perilymph Permeability of Cephalosporins and its Significance in the Treatment and Prevention of Suppurative Labyrinthitis. Annals of Otology, Rhinology & Laryngology 105 (1): 54-57.

Sun, A.H., L.S. Parnes, and D.J. Freeman. 1995. Pharmacokinetic Profiles of Ceftazidime in Cochlear Perilymph, Cerebrospinal Fluid and Plasma: A High Performance Liquid Chromatographic Study. Journal for Oto-Rhino-Laryngology (ORL) 57: 256-259.

Toth, A.A., and L.S. Parnes. 1995. Intratympanic Gentamicin Therapy for Meniere's Disease: Preliminary Comparison of Two Regimens. Journal of Otolaryngology 24 (6): 340-344.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Manninen, P.H., B. Ayra, A.W. Gelb, and D.M. Pelz. 1996. Association Between Electrocardiographic Abnormalities and Intracranial Blood in Patients Following Acute Subarachnoid Hemorrhage. Journal of Neurosurgical Anesthesiology 7 (1): 12-16.

Pelz, D.M. 1995. Interventional neuroradiology. Baillière's Clinical Neurology 4 (2): 297-315.

Chen, R.E., F. Grand'Maison, M.J. Strong, D.A. Ramsay, and C.F. Bolton. 1996. Motor Neuron Disease Presenting as Acute Respiratory Failure: A Clinical and pathological study. Journal of Neurology, Neurosurgery and Psychiatry 60: 455-458.

Chen, R., D.R. Macdonald, and D.A. Ramsay. 1995. Primary diffuse leptomeningeal oligodendroglioma. Journal of Neurosurgery 83 (Oct.): 724-728.

Fisman, M., D.A. Ramsay, and M. Weiser. 1996. Dementia in the Elderly Male Alcoholic - A Retrospective Clinicopathological Study. International Journal of Geriatric Psychiatry 11: 209-218.

Li, Y.S., D.A. Ramsay, Y.S. Fan, R.F. Armstrong, and R.F. Del Maestro. 1995. Cytogenetic Evidence that a Tumor Suppressor Gene in the Long Arm of Chromosome 1 Contributes to Glioma Growth. Cancer Genetics and Cytogenetics 84: 46-50.

Pahapill, P.A., D.A. Ramsay, and R.F. Del Maestro. 1996. Pleomorphic xanthoastrocytoma: A case report, review of the literature and proposal for two clinicolpathological subtypes. Journal of Neurosurgery 38 (4): 822-829.

Parker, B.L., T.C. Frewen, S.D. Levin, D.A. Ramsay, G.B. Young, R.H. Reid, N.C. Singh, and J.M.R. Gillett. 1995. Declaring pediatric brain dealth: current practice in a Canadian pediatric critical care unit. Canadian Medical Association Journal 153 (7): 909-916.

Ramsay, D.A., J. Bonnin, D.R. Macdonald, and L.J. Assis. 1995. Medulloblastomas in late middle age and the elderly: report of 2 cases. Clinical Neuropathology 14 (6): 337-342.

Ramsay, D.A., Y.S. Fan, R.F. Armstrong, R.F. Del Maestro, and Y.S. Li. 1995. Chromosome abnormalities in glioma with particular reference to extra dark bands on the tip of the short arm of chromsome I. Cancer Genetics and Cytogenetics 84: 46-50.

Watling, C.J., D.J. Van Meyel, D.A. Ramsay, D.R. MacDonald, and J.G. Cairncross. 1995. Loss of heterozygosity analysis of chromosomes 9, 10 and 17 in gliomas in families. Canadian Journal of Neurological Sciences 22: 17-21.

Young, G.B., and D.A. Ramsay. 1996. Atlas of Infectious Diseases. The Nervous System in Sepsis and Endocarditis, Volume III. Philadelphia, PA: Churchill Livingstone. 920-923.

Kent, S.J., S.J. Karlik, G.P.A. Rice, and H.C. Horner. 1995. A Monoclonal Antibody to a 4-Integrin Reverses the MR-Detectable Signs of Experimental Allergic Encephalomyelitis in the Guinea Pig. Journal of Magnetic Resonance Imaging 5 (5): 535-540.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Evaluating the Impact on Operator Performance of Quantification Algorithms. Medical Imaging 1996 - Image Processing. Newport Beach, CA: 12 February 1996-15 February 1996. SPIE Proceedings, Volume 2710. Bellingham, Washington: Society of Photo-Optical Instrumentation Engineers (SPIE). 524-533.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. Quantification of multiple sclerosis lesion volumes in 1.5 and 0.5T anisotropically filtered and unfiltered MR exams. Medical Physics 23 (1): 115-126.

Mitchell, J.R., S.J. Karlik, D.H. Lee, M. Eliasziw, G.P.A. Rice, and A. Fenster. 1996. The variability of manual and computer assisted quantification of multiple sclerosis lesion volumes. Medical Physics 23 (1): 85-97.

Picard, F.J., M.B. Coulthard, J. Oger, E.E. King, S. Kim, J. Arp, G.P.A. Rice, and G.A. Dekaban. 1995. Human T-Lymphotrophic Virus type 1 in Coastal Natives of British Columbia: Phylogenetic Affinities and Possible Origins. Journal of Virology 69 (11): 7248-7248.

Poland, S.D., G.A. Dekaban, P.C. Costello, and G.P.A. Rice . 1995. Cytomegalovirus-caused Release of Collagenase IV from Human Cerebral Microvascular Endothelial Cells. Clinical and Diagnostic Virology 4: 301-309.

Rice, G.P.A., and G.C. Ebers. 1995. Management of Multiple Sclerosis in Women. The Female Patient 20 (Sept.): 19-33.

Rice, G.P.A., and The IFNB Multiple Sclerosis Study Group. 1285. Interferon Beta-1b in the Treatment of Multiple Sclerosis: Final Outcome of the Randomized Controlled Trial. Neurology 45 (7): 1277-1285.

Sadovnick, A.D., G.C. Ebers, D.A. Dyment, N.J. Risch, Canadian Collaborative Study Group , D.E. Bulman, and G.P.A. Rice. 1996. Evidence for genetic basis of multiple sclerosis. Lancet 347 (June): 1728-1730.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Sahjpaul, R.L., K. Elisevich, and L. Allen. 1996. Hodgkin's Disease of the Orbit with Intracranial Extension. Ophthalmic Surgical Lasers 27: 239-242.

Gogan, N., C.D. Bayliff, N.A.M. Paterson, and J.D. Spence. 1995. Clinical Consequences of Quinolone-Theophylline Interactions. Canadian Journal of Hospital Pharmacy 48 (6): 366-369.

Hachinski, V., C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, A.P. Donner, J.D. Spence, G.S. Doig, and B.M. Wolfe. 1996. Lipids and Stroke: A paradox resolved. Archives of Neurology 53 (April): 303-308.

Ogilvie, R.I., E. Ellis, S. Langlois, R. MacKenzie, and J.D. Spence. 1996. Guidelines : Recommendations for sick-leave from work for patients with hypertension. Canadian Journal of Cardiology 12 (1): 31-32.

Spence, J.D. 1995. Advances in Atherosclerosis (Chapter 1). Bailliere's Clinical Neurology: Cerebrovascular Disease 4 (2): 191-205.

Spence, J.D. (1996). Cerebral Consequences of Arterial Hypertension: Stroke prevention in the high-risk patient. Satellite Symposium: An Update on Hypertension and Stoke. 9-11.

Spence, J.D. 1995. Cerebral Consequences of Hypertension (Chapter 43). Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. J.H. Laragh, and B.M. Brenner. New York, NY: Raven Press. 741-753.

Spence, J.D. 1995. Pseudohypertension (Chapter 2). Hypertension: Pathophyisology, Diagnosis, and Management. J.H. Laragh, and B.M. Brenner. New York, NY: Raven Press. 1929-1937.

Spence, J.D., M.W. Huff, A.P. Heidenheim, A. Viswanatha, C. Munoz, R. Lindsay, B.M. Wolfe, and D. Mills. 1995. Combination therapy with colestipol an psyllium mucilloid in patients with hyperlidemia. Annals of Internal Medicine 123 (7): 493-499.

Spence, J.D., D.G. Munoz, L. Hendricks, L. Latchinian, and H.E. Khouri. 1995. Pharmacokinetics of the combination of fluvastatin and gemifibrozil. American Journal of Cardiology 76 (July): 80A-83A.

Parboosingh, J.S., M. Rousseau, F. Rogan, Z. Amit, H. Chertkow, W.G. Johnson, F. Manganaro, H.N. Schipper, T.J. Curran, A.J. Stoessl, and G. Rouleau. 1995. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease. Archives of Neurology 52 (12): 1160-1163.

Stoessl, A.J. 1996. Effects of ethanol in a rodent model of tardive dyskinesia. Pharmacology, Bichemistry and Behaviour 54: 541-546.

Stoessl, A.J., M. Brackstone, N. Rajakumar, and C.J. Gibson. 1995. Pharmacological characterization of grooming induces by a selective NK-1 tachykinin receptor agonist. Brain Research 700: 115-120.

Van Kampen, J., H. Frydryszak, and A.J. Stoessl. 1996. Behavioural evidence for Cholecystokinin-D1 Dopamine receptor interactions in the rat. European Journal of Pharmacology 298: 7-15.

Chen, R.E., F. Grand'Maison, M.J. Strong, D.A. Ramsay, and C.F. Bolton. 1996. Motor Neuron Disease Presenting as Acute Respiratory Failure: A Clinical and pathological study. Journal of Neurology, Neurosurgery and Psychiatry 60: 455-458.

Ferguson, K.A., M.J. Strong, D. Ahmad, and C.F.P. George. 1996. Sleep and Breathing in Amyotrophic Lateral Sclerosis. Sleep 110 (3): 664-669.

Gaytan-Garcia, S., H. Kim, and M.J. Strong. 1996. Spinal Motor Neuron Neuroaxonal Spheroids in Chronic Aluminum Neurotoxicity Contain Phosphatase-resistant High Molecular Weight Neurofilament (NFH). Toxicology 108: 17-24.

A:S CNTF Treatment Study Group, M.J. Strong, et al. 1996. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic fctor (rHCNTF) in amyotrophic lateral sclerosis . Neurology 446 (May): 1244-1249.

Strong, M.J. 1996. ALS: update of a tragic illness. Medicine North America (Sept.): 780-788.

Strong, M.J., R.M. Garruto, J.G. Joshi, W.R. Mundy, and T.J. Shafer. 1996. Can the mechanisms of aluminum neurotoxicity be integrated into a unified scheme? Journal of Toxicology and Environmental Health 48: 599-613.

Strong, M.J., and S. Gaytan-Garcia. 1996. Proximal sciatic axotomy does not inhibit the induction of neurofilamentous inclusions following intracisternal aluminum chloride exposure. Journal of Neuropathology and Experimental Neurology 55 (4): 419-423.

Strong, M.J., G.M. Grace, J.B. Orange, and H.A. Leeper. 1996. Cognition, Language and Speech in Amyotrophic Lateral Sclerosis: A review. Journal of Clinical and Experimental Neuropsychology 18 (2): 291-303.

Ye, Y., M.J. Strong, H.Q. Huang, and J.S. Beckman. 1996. Antobodies that Recognize Nitrotyrosine. Nitric Oxide, Part B: Physiology and Pathological Processes. Methods in Enzymology. 269 ed. San Diego, CA: Academic Press, Inc. 201-209.

Lee, D.H., J.M. Rogers, R. Sevick, L. Hewett, M. Eliasziw, S. Dunlavy, J.P. Girvin, A.G. Parrent, W.T. Blume, R.S. McLachlan, S. Wiebe-Velazquez, I.R.A. MacKenzie, and D.G. Munoz. 1996. Technology Assessment in Canada: Comparision of Magnetic Field Strength in the Assessment of Complex Partial Seizures. Academic Radiology 3: S60-S61.

Rose, K.J., P.A. Derry, S. Wiebe-Velazquez, and R.S. McLachlan. 1996. Determinants of HealthRelated Quality of Life after Temporal Lobe Epilepsy Surgery. Quality of Life Research 5: 395-402.

Wiebe-Velazquez, S. 1996. An unusual mechanism of recombent syncope. Lancet 347 (9017): 1769-1770.

Morrison-Stewart, S., D. Velikonja, W.C. Corning, and P.C. Williamson. 1996. Aberrant Interhemispheric Alpha Coherence on Electroencephalography in Schizophrenic Patients During Activation Tasks. Psychological Medicine 26: 605-612.

Neufeld, R.W.J., and P.C. Williamson. 1996. Neuropsychological Correlates of Positive Schizophrenic Symptoms. The Neuropsychology of Schizophrenia. C. Pantelis, H.E. Nelson, and T.R.E. Barnes. London: John Wiley & Sons.

Velamoor, V.R., G.N. Swamy, R.S. Parmar, P.C. Williamson, and S.N. Caroff. 1995. Management of Suspected Neuroleptic Malignant Syndrome. Canadian Journal of Psychiatry 40 (Nov.): 545-550.

Williamson, P.C. 1996. Imaging (Chapter 37). Images in Psychiatry: Canada. Q. Rae-Grant. Washington DC: American Psychiatric Press. 249-255.

Bayliff, C.D., J. Bruni, S. Cowan, K. Farrell, M. Sadler, R.S. McLachlan, and G.B. Young. 1996. Antiepileptic Drug Therapy. Compendium of Pharmaceuticals and Specialties (CPS). 1996 ed. Ottawa, Ontario: Canadian Pharmaceutical Association. L44-L46.

Bolton, C.F., and G.B. Young. 1996. Neurologic Manifestations of Renal Failure and Dialysis (Chapter 185, Section 3). Office Practice of Neurology. New York, NY: Churchill Livingstone. 999-1005.

Chen, R., C.F. Bolton, and G.B. Young. 1996. Prediction of Outcome in Patients with Anoxic Coma: A clinical and electrophysiologic study. Critical Care Medicine 24 (4): 672-678.

Parker, B.L., T.C. Frewen, S.D. Levin, D.A. Ramsay, G.B. Young, R.H. Reid, N.C. Singh, and J.M.R. Gillett. 1995. Declaring pediatric brain dealth: current practice in a Canadian pediatric critical care unit. Canadian Medical Association Journal 153 (7): 909-916.

Young, G.B. 1996. The Encephalopathy Associated with Sepsis. Current Problems in Emergency and Intensive Care Medicine: Organ Dysfunction. Stuttgart-New York: Thieme Publishers. 14-17.

Young, G.B. 1995. Neurological complications of systemic critical illnesses. Neurologic Clinics: Neurologic Critical Care 13 (3): 645-658.

Young, G.B., K.G. Jordan, and G.S. Doig. 1996. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: An investigation of variables associated with mortality. Neurology 47: 83-89.

Young, G.B., and D.A. Ramsay. 1996. Atlas of Infectious Diseases. The Nervous System in Sepsis and Endocarditis, Volume III. Philadelphia, PA: Churchill Livingstone. 920-923.

Zifko, U.A., P.J. Slomka, R.H. Reid, G.B. Young, H. Remtulla, and C.F. Bolton. 1996. The cortical representation of somatosensory evoked potentials of the phrenic nerve. Journal of the Neurological Sciences 139: 197-202.

Zifko, U.A., P.J. Slomka, G.B. Young, R.H. Reid, and C.F. Bolton. 1996. Brain Mapping of Median Nerve Somatosensory Evoked Potentials with Combined ^99mTc-ECD single-photon emission tomography and magnetic resonance imaging. European Journal of Nuclear Medicine 23 (5): 579-582.

Zifko, U.A., G.B. Young, H. Remtulla, and C.F. Bolton. 1995. Somatosensory Evoked Potentials of the Phrenic Nerve. Muscle and Nerve 18 (Dec.): 1487-1489.